Federal Register / Vol. 82, No. 165 / Monday, August 28, 2017 / Notices 40779 

NICHD and its customers and 

stakeholders. It will also allow feedback 

to contribute directly to the 

improvement of program management. 

The solicitation of feedback will target 

areas such as: Timeliness, 

appropriateness, accuracy of 

information, courtesy, efficiency of 

service delivery, and resolution of 

issues with service delivery. Responses 

will be assessed to plan and inform 

efforts to improve or maintain the 

quality of service offered to the public. 

If this information is not collected, vital 

feedback from customers and 

stakeholders on the NICHD’s services 

will be unavailable. 

The NICHD will only submit a 

collection for approval under this 

generic clearance if it meets the 

following conditions: 

• The collections are voluntary; 

• The collections are low-burden for 

respondents (based on considerations of 

total burden hours, total number of 

respondents, or burden-hours per 

respondent) and are low-cost for both 

the respondents and the Federal 

Government; 

• The collections are noncontroversial and do not raise issues of 

concern to other Federal agencies; 

• Any collection is targeted to the 

solicitation of opinions from 

respondents who have experience with 

the program or may have experience 

with the program in the near future; 

• Personally identifiable information 

(PII) is collected only to the extent 

necessary and is not retained; 

• Information gathered will be used 

only internally for general service 

improvement and program management 

purposes and is not intended for release 

outside of the agency; 

• Information gathered will not be 

used for the purpose of substantially 

informing influential policy decisions; 

and 

• Information gathered will yield 

qualitative information; the collections 

will not be designed or expected to 

yield statistically reliable results or used 

as though the results are generalizable to 

the population of study. 

Feedback collected under this generic 

clearance provides useful information, 

but it does not yield data that can be 

generalized to the overall population. 

This type of generic clearance for 

qualitative information will not be used 

for quantitative information collections 

that are designed to yield reliably 

actionable results, such as monitoring 

trends over time or documenting 

program performance. Such data uses 

require more rigorous designs that 

address: The target population to which 

generalizations will be made, the 

sampling frame, the sample design 

(including stratification and clustering), 

the precision requirements or power 

calculations that justify the proposed 

sample size, the expected response rate, 

methods for assessing potential nonresponse bias, the protocols for data 

collection, and any testing procedures 

that were or will be undertaken prior to 

fielding the study. Depending on the 

degree of influence the results are likely 

to have, such collections may still be 

eligible for submission for other generic 

mechanisms that are designed to yield 

quantitative results. 

As a general matter, information 

collections will not result in any new 

system of records containing privacy 

information and will not ask questions 

of a sensitive nature, such as sexual 

behavior and attitudes, religious beliefs, 

and other matters that are commonly 

considered private. 

OMB approval is requested for 3 

years. There are no costs to respondents 

other than their time. The total 

estimated annualized burden hours are 

4,950. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of collection Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total annual 

burden hours 

Conference/Training—Pre and Post Surveys .................................................. 100 1 15/60 25 

Usability Testing .............................................................................................. 100 1 30/60 50 

Focus Groups .................................................................................................. 750 1 1 750 

Customer Satisfaction Survey ......................................................................... 13,500 1 15/60 3,375 

In-depth Interviews or Small Discussion Group .............................................. 750 1 1 750 

Total .......................................................................................................... 15,200 15,200 ........................ 4,950 

Dated: August 23, 2017. 

Jennifer Guimond, 

Project Clearance Liaison, Eunice Kennedy 

Shriver National Institute of Child Health and 

Human Development, National Institutes of 

Health. 

[FR Doc. 2017–18195 Filed 8–25–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of the Secretary Notice of 

Meeting 

Notice is hereby given of the 

cancellation of the Muscular Dystrophy 

Coordinating Committee meeting, 

October 4, 2017, 8:30 a.m. to 4:30 p.m., 

National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Conference Room C/D, 

Bethesda, MD 20852 which was 

published in the Federal Register on 

August 11, 2017, 82 FR 37595, pages 

37595–37596. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.853, Clinical Research 

Related to Neurological Disorders; 93.854, 

Biological Basis Research in the 

Neurosciences, National Institutes of Health, 

HHS) 

Dated: August 22, 2017. 

Sylvia L. Neal, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–18123 Filed 8–25–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Biomedical 

Imaging and Bioengineering; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Institute of 


asabaliauskas on DSKBBXCHB2PROD with NOTICES
40780 Federal Register / Vol. 82, No. 165 / Monday, August 28, 2017 / Notices 

Biomedical Imaging and Bioengineering 

Special Emphasis Panel. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Biomedical Imaging and Bioengineering 

Special Emphasis Panel, NIBIB P41 Review 

(2018/01). 

Date: September 17–19, 2017. 

Time: 5:00 p.m. to 12:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Courtyard Los Angeles LA Live, 901 

West Olympic Boulevard, Los Angeles, CA 

90015. 

Contact Person: Ruixia Zhou, Ph.D., 

Scientific Review Officer, 6707 Democracy 

Boulevard, Democracy Two Building, Suite 

957, Bethesda, MD 20892, (301) 496–4773, 

zhour@mail.nih.gov. 

Dated: August 22, 2017. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–18122 Filed 8–25–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Biomedical 

Imaging and Bioengineering Notice of 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Advisory 

Council for Biomedical Imaging and 

Bioengineering. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications 

and/or contract proposals and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications and/or contract proposals, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Advisory 

Council for Biomedical Imaging and 

Bioengineering NACBIB Council Meeting, 

September, 2017. 

Date: September 12, 2017. 

Open: 9:00 a.m. to 12:40 p.m. 

Agenda: Report from the Institute Director, 

other Institute Staff and scientific 

presentation. 

Place: The William F. Bolger Center, 

Franklin Building, Classroom 4, 9600 

Newbridge Drive, Potomac, MD 20854. 

Closed: 2:00 p.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications and/or proposals. 

Place: The William F. Bolger Center, 

Franklin Building, Classroom 4, 9600 

Newbridge Drive, Potomac, MD 20854. 

Contact Person: David T. George, Ph.D., 

Acting Associate Director, Office of Research 

Administration, National Institute of 

Biomedical Imaging and Bioengineering, 

6707 Democracy Boulevard, Room 920, 

Bethesda, MD 20892. 

Any interested person may file 

written comments with the committee 

by forwarding the statement to the 

Contact Person listed on this notice. The 

statement should include the name, 

address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Information is also available on the 

Institute’s/Center’s home page: http://

www.nibib1.nih.gov/about/NACBIB/ 

NACBIB.htm, where an agenda and any 

additional information for the meeting 

will be posted when available. 

Dated: August 22, 2017. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–18120 Filed 8–25–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Neurological 

Disorders and Stroke 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of an 

Interagency Pain Research Coordinating 

Committee (IPRCC) meeting. 

The meeting will feature invited 

speakers and discussions of committee 

business items including updates on the 

Federal Pain Research Strategy and new 

pain initiatives. 

The meeting will be open to the 

public and accessible by live webcast 

and conference call. 

Name of Committee: Interagency Pain 

Research Coordinating Committee. 

Type of meeting: Open Meeting. 

Date: October 23, 2017. 

Time: 8:30 a.m. to 4:30 p.m. *Eastern 

Time*—Approximate end time. 

Agenda: The meeting will feature invited 

speakers and discussions of Committee 

business items including updates on the 

Federal Pain Research Strategy and new pain 

initiatives. 

Place: National Institutes of Health, 

Building 31C, 6th Floor, Room 6, 31 Center 

Drive, Bethesda, MD 20892. 

Cost: The meeting is free and open to the 

public. 

Webcast Live: http://videocast.nih.gov/. 

Deadlines: Notification of intent to present 

oral comments: Monday, October 17, 2017, 

by 5:00 p.m. ET. Submission of written/ 

electronic statement for oral comments: 

Monday, October 17, 2017, by 5:00 p.m. ET. 

Submission of written comments: Monday, 

October 17, 2017, by 5:00 p.m. ET. 

Access: Medical Center Metro (Red Line). 

Visitor Information: http://www.nih.gov/ 

about/visitor/index.htm. 

Contact Person: Linda L. Porter, Ph.D., 

Pain Policy Advisor, Office of Pain Policy, 

Officer of the Director, National Institute of 

Neurological Disorders and Stroke, NIH, 31 

Center Drive, Room 8A31, Bethesda, MD 

20892, Phone: (301) 451–4460, Email: 

Linda.Porter@nih.gov. 

Please Note: Any member of the public 

interested in presenting oral comments to the 

Committee must notify the Contact Person 

listed on this notice by 5:00 p.m. ET on 

Monday, October 17, 2017, with their request 

to present oral comments at the meeting. 

Interested individuals and representatives of 

organizations must submit a written/ 

electronic copy of the oral statement/ 

comments including a brief description of the 

organization represented by 5:00 p.m. ET on 

Monday, October 17, 2017. 

Statements submitted will become a part of 

the public record. Only one representative of 

an organization will be allowed to present 

oral comments on behalf of that organization, 

and presentations will be limited to three to 

five minutes per speaker, depending on 

number of speakers to be accommodated 

within the allotted time. Speakers will be 

assigned a time to speak in the order of the 

date and time when their request to speak is 

received, along with the required submission 

of the written/electronic statement by the 

specified deadline. If special 

accommodations are needed, please email 

the Contact Person listed above. 

In addition, any interested person may 

submit written comments to the IPRCC prior 

to the meeting by sending the comments to 

the Contact Person listed on this notice by 

5:00 p.m. ET, Monday, October 17, 2017. The 

comments should include the name and, 

when applicable, the business or professional 

affiliation of the interested person. All 

written comments received by the deadlines 


asabaliauskas on DSKBBXCHB2PROD with NOTICES